Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.

Cancer 2016 Feb 13;122(4):559-64. Epub 2015 Nov 13.

Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois.

Background: Double-hit lymphomas (DHLs) are collectively defined as B-cell non-Hodgkin lymphomas harboring rearrangements of MYC as well as B-cell lymphoma 2 (BCL2) and/or B-cell lymphoma 6 (BCL6). To the authors' knowledge, the impact of specific oncogene rearrangements on outcomes of patients with DHL who are treated with immunochemotherapy has not been previously described.

Methods: The authors identified patients whose diagnostic tissue specimens underwent metaphase karyotyping or fluorescence in situ hybridization for MYC as well as both BCL2 and BCL6 rearrangements. Cohorts were defined by the presence (+) or absence (-) of rearrangements: MYC+/BCL2+/BCL6- (BCL2-DHL), MYC+/BCL2-/BCL6+ (BCL6-DHL), and MYC+/BCL2+/BCL6+ (triple-hit lymphoma; THL).

Results: A total of 117 patients were included in the current analysis (76 BCL2-DHL patients, 16 BCL6-DHL patients, and 25 THL patients). Compared with patients with BCL2-DHL, those with BCL6-DHL were more likely to be classified as having a non-germinal center cell of origin, presented with extranodal disease, and appeared to achieve higher rates of complete response despite receiving intensive induction therapy less frequently. However, patients with BCL6-DHL experienced a shorter median overall survival if achieving an initial complete response compared with patients with BCL2-DHL. Patients with THL experienced survival outcomes similar to those of patients with BCL2-DHL.

Conclusions: Recognition of the specific oncogene rearrangements may be of prognostic value and potentially guide future therapeutic strategies for patients with DHL.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068487PMC
http://dx.doi.org/10.1002/cncr.29781DOI Listing
February 2016
131 Reads

Publication Analysis

Top Keywords

patients
13
outcomes patients
12
patients thl
8
compared patients
8
patients bcl6-dhl
8
bcl2-dhl patients
8
patients dhl
8
oncogene rearrangements
8
specific oncogene
8
b-cell lymphoma
8
patients bcl2-dhl
8
myc well
8
complete response
8
rearrangements
5
higher rates
4
rearrangements myc+/bcl2+/bcl6-
4
absence rearrangements
4
rates complete
4
presence absence
4
bcl2-dhl
4

Altmetric Statistics

References

(Supplied by CrossRef)
Double-hit B-cell lymphomas
Aukema et al.
Blood 2011

Similar Publications